Page 31 - MemoriaCIBER-2018ENG

Nanomedicine
Coordinator: M. Pilar Marco Colás
In 2018 52 new intramural cooperation schemes were started up in the Nanomedicine Area, 25 of these for performance in cooperation with other thematic areas of the CIBER and 10 with groups outside this. As an innovation this year 14 Early Stage projects have been got under way in the Nanomedicine area led by CIBER contracted staff.
We should stress the efforts made by CIBER-BBN in the preparation of competitive proposals. Among these the researchers from the Nanomedicine Programme of CIBER-BBN have continued with internationally and nationally financed projects such as:
• European project SMART-4-FABRY “Smart multifunctional GLA-nanoformulation for Fabry Disease”, coordinated by CIBER (PI: Nora Ventosa).
• European project “Exploitation of extracellular vesicles for precision diagnostics of prostate cancer – PROSCANEXO” ERANET-TRANSCAN-2 (JTC2016) coordinated by CIBER (PI: Jesús Martínez de la Fuente).
• Continuation of Phase I of European project “Integrated Precision Medicine Research Center of Excelence – IPMT CoE”.
• European project “Monitoring of Acquired Brain Injury and recovery biomarkers by
the combined label-free nanoSensing of multiple circulating molecules – ABISens” EURONANOMED-3 (JTC2018) coordinated by CIBER-BBN, (PI: Laura Lechuga).
• Participation of 15 CIBER-BBN groups in the COST-Action Nano2Clinics project “Cancer Nanomedicine - From bench to bedside”, contributing to the different work groups in the Action. The CIBER-BBN also forms part of the Management Committee for this measure.
• Health research project - AES2017 “Design of protein nanomedicines for treatments tackling cancer of the pancreas” led by contracted researcher José Luis Corchero.
• RETOS project NanoET-Leukemia, led by contracted researchers Anna Lagunas and Marina Inés Giannotti.
Apart from this, researchers from the Nanomedicine area have continued with the ERC obtained:
• ERC Advanced Grants (María Vallet-Regí and Jesús Santamaría with projects VERDI - polyValent mEsopoRous nanosystems for bone DIseases and CADENCE Catalytic Dual-Function Devices Against Cancer, respectively);
• ERC Consolidator: Manuel Arruebo with the project entitled “Nanohedonism and ERC Proof of Concept: HOTFLOW” by Jesús Martinez de la Fuente.
Luis M. Liz Marzán has furthermore obtained an ERC Advanced Grant this year for the project “4DBIOSERS Four-Dimensional Monitoring of Tumour Growth by Surface Enhanced Raman Scattering”.
The following events and congresses connected with the Nanomedicine Area were also attended:
• XI Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica, 5 and 6 March 2018, Barcelona.
• CLINAM European Foundation for Clinical Nanomedicine, Basel 2-6 September 2018.
• Annual meeting of the ETPN (European Technology Platform of Nanomedicine). Berlin, 28–20 May 2018.
• Brokerage Event on Advanced Materials and Nanotechnology. Horizon 2020 NMBP Calls 2019. 3 July, IMDEA Madrid.
Researchers from the Nanomedicine Area Luis M. Liz Marzan and María Vallet-Regí appear on the list of Highly Cited Researchers de Clarivate Analytics,one of the most highly reputed classifications in the international academic and scientific community. The scientific director
of CIBER-BBN, Ramón Martínez Máñez, was furthermore awarded the Premio Rei Jaume I de Nuevas Tecnologías 2018. Luis M. Liz Marzán was also given the National Research Award 2018 in the Chemical Science and Technology Area and Laura Lechuga was appointed associate editor by the Editorial Board of Analyst journal.
31
CIBER-BBN | ANNUAL REPORT 2018